|
Q4 2021
Filed on Feb 11, 2022
|
125,230
|
N/A
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
9,600
|
N/A
|
|
Checkmate Pharmaceuticals In
|
Q4 2021
Filed on Feb 11, 2022
|
10,667
|
N/A
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
51,200
|
N/A
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
33,900
|
$5.93 - $10.61
$201K - $360K
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
10,040
|
N/A
|
|
Invesco Exch Trd Slf Idx Fd
|
Q4 2021
Filed on Feb 11, 2022
|
23,845
|
N/A
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
5,000
|
$48.42 - $66.3
$242K - $332K
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
41,362
|
N/A
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
302,137
|
N/A
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
33,447
|
N/A
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
24,905
|
$13.4 - $16.25
$334K - $405K
|
|
Severn Bancorp Inc Annapolis
|
Q4 2021
Filed on Feb 11, 2022
|
14,500
|
N/A
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
28,600
|
N/A
|
|
Xeris Pharmaceuticals Inc
|
Q4 2021
Filed on Feb 11, 2022
|
142,012
|
N/A
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
8,800
|
N/A
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
158,202
|
$1.62 - $5.69
$256K - $900K
|
|
Irsa Propiedades Comerciales
|
Q4 2021
Filed on Feb 11, 2022
|
61,359
|
N/A
|
|
Exchange Traded Concepts Tr
|
Q4 2021
Filed on Feb 11, 2022
|
17,264
|
N/A
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
72,600
|
$2.18 - $3.93
$158K - $285K
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
42,100
|
$18.67 - $22.66
$786K - $954K
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
13,615
|
N/A
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
25,063
|
$2.17 - $3.7
$54.4K - $92.7K
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
40,300
|
N/A
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
15,935
|
$11.8 - $15.1
$188K - $241K
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
5,500
|
$104.77 - $116.15
$576K - $639K
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
1,199,000
|
N/A
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
94,210
|
N/A
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
29,900
|
$135.09 - $159.72
$4.04M - $4.78M
|
|
17 Ed & Technology Group Inc
|
Q4 2021
Filed on Feb 11, 2022
|
873,300
|
N/A
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
124,603
|
N/A
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
8,200
|
$28.11 - $30.24
$231K - $248K
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
1,074,900
|
$15.44 - $23.16
$16.6M - $24.9M
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
13,600
|
$15.04 - $26.32
$205K - $358K
|
|
Cellect Biotechnology LTD
|
Q4 2021
Filed on Feb 11, 2022
|
36,291
|
N/A
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
10,001
|
$12.0 - $22.48
$120K - $225K
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
941,179
|
N/A
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
980,596
|
$23.06 - $28.75
$22.6M - $28.2M
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
13,500
|
$13.8 - $18.91
$186K - $255K
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
123,900
|
N/A
|
|
Strongbridge Biopharma PLC
|
Q4 2021
Filed on Feb 11, 2022
|
1,371,400
|
N/A
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
120,578
|
N/A
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
150,048
|
N/A
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
100,500
|
N/A
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
202,624
|
N/A
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
44,200
|
N/A
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
152,590
|
N/A
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
218,848
|
$3.09 - $4.81
$676K - $1.05M
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
341,699
|
$20.73 - $24.69
$7.08M - $8.44M
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
61,400
|
N/A
|
|